Johnson & Johnson (JNJ) is trying to resolve tens of thousands of claims from plaintiffs who say the talc in its iconic baby powder once contained asbestos that caused ovarian and tissue cancers.
So far J&J's stock has held steady during the nearly two-year-long legal battle. That resilience is about to be put to the test.
A US bankruptcy court is expected to rule by Aug. 2…